Should irradiated blood products be given routinely to all patients with aplastic anaemia undergoing immunosuppressive therapy with antithymocyte globulin (ATG)? A survey from the European Group for Blood and Marrow Transplantation Severe Aplastic Anaemia Working Party.
Marsh
Judith
J
Socie
Gerard
G
Tichelli
Andre
A
Schrezenmeier
Hubert
H
Hochsmann
Britta
B
Risitano
Antonio M
AM
Fuehrer
Monika
M
Bekassy
Albert N
AN
Korthof
Elizabeth T
ET
Locasciulli
Anna
A
Ljungman
Per
P
Bacigalupo
Andrea
A
Camitta
Bruce
B
Young
Neal S
NS
Passweg
Jakob
J
D000741:Anemia, Aplastic / Q000628:therapy*; D000961:Antilymphocyte Serum / Q000627:therapeutic use*; D001769:Blood / Q000528:radiation effects; D016913:Blood Component Transfusion / Q000706:statistics & numerical data*; D016026:Bone Marrow Transplantation; D006086:Graft vs Host Disease / Q000517:prevention & control; D019538:Health Care Surveys; D006801:Humans; D007166:Immunosuppressive Agents / Q000627:therapeutic use*
D000961:Antilymphocyte Serum; D007166:Immunosuppressive Agents